Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Must Reads by Date
Must reads for theWeek ending November 1, 2015
FDA Approves Coagadex, Indicated for Factor X deficiency
Diagnostic PET-CT and Multiple Myeloma, Identifying patients needing therapy
Rd Therapy in Multiple Myeloma, Studying the cytogenetics of exceptional responders
Sirolimus as Cytopenia Monotherapy, Studying responses in pediatric patients
FDA Approves Onivyde , Indicated for metastatic pancreatic cancer
Must reads for theWeek ending October 25, 2015
Defining “Clinically Relevant Non-Major Bleeding”, ISTH releases recommended definition
Micro-RNAs in Multiple Myeloma, Assessing the effects of changes
Recombinant Factor VIIa in Hemophilia, Studying the immunogenicity of vatrepacog alfa
Risk of AML and MDS After First Cancers, Are type of cancer and radiation status informative?
STILs as Prognosticators of Recurrence-Free Survival, Does trastuzumab affect predictions?
Must reads for theWeek ending October 18, 2015
Genomic Associations in DLBCL, Searching for loci associated with survival
Hodgkin Lymphoma Among US Servicemen, Do childhood viral infections confer risk?
Family Histories and Multiple Myeloma, Associations with discordant cancers
Exercise and Sickle Cell Anemia, Is taking it easy the way to go?
MDS and AML in Breast Cancer, Studying associations with therapies
Must reads for theWeek ending October 11, 2015
Allogeneic STC in Cutaneous T-cell Lymphoma, Studying remission in common variants
CMV Reactivation in Allogeneic HCT, Does it have a protective effect?
Comorbid Conditions in CML, Researching conditions that affect TKI selection
Single Nucleotide Polymorphisms in MDS, A new scoring system for predicting survival
Cabozantinib in Advanced Renal-cell Carcinoma, Comparing it with everolimus
Must reads for theWeek ending October 4, 2015
2015 Guideline on Myelodysplastic Syndromes, Covers diagnosis, risk-stratification, therapy, and management
Verurafenib in Hairy-Cell Leukemia, Targeting mutant BRAF V600E
Lifestyle and Environmental Exposures in AML, Studying associations with risk
Umbilical Cord Blood Transfusions in AML, Are they effective in older patients?
Metformin in Colorectal Cancer, How does it affect adenoma risk?